Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis
Cytomegalovirus (CMV) central nervous system disease after hematopoietic stem cell transplantation (HSCT) is a rare but life-threatening complication. Here, we report a patient who developed CMV meningitis after HSCT and was treated with the combination therapy of intrathecal high-titer CMV immunog...
Main Authors: | Shin-ichiro Fujiwara, Kazuo Muroi, Raine Tatara, Ken Ohmine, Tomohiro Matsuyama, Masaki Mori, Tadashi Nagai, Keiya Ozawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2014/272458 |
Similar Items
-
Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure
by: Sandra Jaksic Jurinjak, et al.
Published: (2021-02-01) -
Cytomegalovirus myocarditis with rapid response to intravenous immunoglobulin therapy
by: Sercan Yücel Yanmaz, et al.
Published: (2018-09-01) -
Cytomegalovirus-associated biliary atresia
by: Kazuki Kodo, et al.
Published: (2018-08-01) -
Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection
by: Yuka Torii, et al.
Published: (2019-06-01) -
Correspondence Between Cytomegalovirus Immunoglobulin-G Levels Measured in Saliva and Serum
by: Jenna L. Riis, et al.
Published: (2020-08-01)